Microbot Medical wins Israeli approval for LIBERTY robotic system, opens path to global markets

Filed May 26, 2026 · Period ending May 26, 2026 · ~1 min read

Key Changes

• high

  Israeli Ministry of Health approved LIBERTY Endovascular Robotic System for marketing and commercialization in Israel, marking the company's first regulatory clearance in its home market.

  Item 7.01 verify on EDGAR →
• high

  Approval enables Microbot to obtain a Free Sale Certificate, which can be used to support regulatory submissions and commercial activities in additional international jurisdictions.

  Item 7.01 verify on EDGAR →
• medium

  LIBERTY is a robotic system designed for endovascular procedures; Israeli approval represents a key milestone in the company's commercialization strategy.

  Item 7.01 verify on EDGAR →